Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT02435511 · ClinicalTrials.gov registry record · NA

Study the Impact of the CommunityRx Program on Health, Self-care and Cost

A NA study, sponsored by University of Chicago.

Completed
Registry status
NA
Development phase
411
Enrollment target

NCT02435511 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 411 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT02435511, a NA study, has completed, sponsored by University of Chicago.

COMPLETED
Registry status
NA
Development phase
411 participants
Enrollment target

Study Summary

CommunityRx is a health information technology-based innovation that, starting with the patient-health care provider encounter, facilitates self-care coordination for patients, caregivers, and providers. The CommunityRx database interfaces with electronic medical records to provide patients with a "HealtheRx." A HealtheRx is a list of community-based self-care resources tailored to the patients health needs (e.g., a person with diabetes receives information about podiatrists, nutrition classes, and other resources need to manage diabetes). CommunityRx aims to measurably improve health and health care while reducing health care costs especially in underserved health care settings. Specifically, the proposed research aims to 1) evaluate the impact of CommunityRx on health care utilization, cost, health, and patient-centered outcomes for program participants compared to controls; 2) examine the flow and spread of information to and through primary agents including: program participants, community health information experts, healthcare providers, and community-based service providers (businesses and organizations providing self-care resources); and 3) build and use an agent-based model to test the distributed impact, including economic effects, of CommunityRx system adoption on the demonstration area and predict performance over time by conducting experiments that vary assumptions about agent, environment, and population-level characteristics.

Interventions

  • OTHER HealtheRx

Trial Details

FieldValue
Enrollment Target 411 participants
Start Date 2015-12
Est. Completion 2017-12
Phase NA

Sponsor

University of Chicago

796 total trials

What the Registry Record Tells You About NCT02435511

The ClinicalTrials.gov registry entry for NCT02435511 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 411 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Chicago, which has 796 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which HealtheRx is the first listed.

NCT02435511 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT02435511 about?

NCT02435511 is a clinical study titled "Study the Impact of the CommunityRx Program on Health, Self-care and Cost". CommunityRx is a health information technology-based innovation that, starting with the patient-health care provider encounter, facilitates self-care coordination for patients, caregivers, and providers. The CommunityRx database interfaces with electronic medical records to provide patients with a "...

What is the current status of trial NCT02435511?

This trial is currently completed. It is a NA study. The enrollment target is 411 participants. The study started on 2015-12. Estimated completion is 2017-12.

What interventions are being tested in trial NCT02435511?

The interventions under investigation include: HealtheRx (OTHER).

Who is sponsoring clinical trial NCT02435511?

This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.